Key Financial Data Of Group

Daito Pharmaceutical Co., Ltd. - Filing #7542348

Concept 2023-06-01 to
2023-08-31
As at
2023-08-31
As at
2023-05-31
2022-06-01 to
2023-05-31
As at
2022-08-31
2022-06-01 to
2022-08-31
Key financial data of group
Business results of group
Net sales
12,178,000,000 JPY
45,101,000,000 JPY
12,041,000,000 JPY
Ordinary profit (loss)
1,092,000,000 JPY
5,169,000,000 JPY
1,475,000,000 JPY
Profit (loss) attributable to owners of parent
683,000,000 JPY
3,600,000,000 JPY
946,000,000 JPY
Comprehensive income
793,000,000 JPY
4,038,000,000 JPY
1,238,000,000 JPY
Net assets
51,332,000,000 JPY
50,971,000,000 JPY
48,714,000,000 JPY
Total assets
71,516,000,000 JPY
70,552,000,000 JPY
69,422,000,000 JPY
Basic earnings (loss) per share
43.27
227.63
59.74
Diluted earnings per share
227.42
Equity-to-asset ratio
0.714 xbrli:pure
0.718 xbrli:pure
0.696 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.